AQST
insider transactionsAquestive Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-33.3K
0 buy · 33.3K sell
Net value · 90d
-$139.4K
$0 in · $139.4K out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
2
0 buy · 33.3K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 90d
-
Sell·S
Barber Daniel KEY
President and CEO · 10b5-1
$104.0K
25.0K sh · $4.16
Own -4%
-
Sell·S
Barber Daniel KEY
President and CEO · 10b5-1
$35.4K
8.3K sh · $4.29
Own -1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Barber Daniel KEY 10b5-1 | Sell S | 25.0K | $104.0K |
| May 15, 2026 | Barber Daniel KEY 10b5-1 | Sell S | 8.3K | $35.4K |
Buy Sell Non-market (grant · exercise · gift)
About AQST insider trading
This page tracks insider transactions for Aquestive Therapeutics, Inc. (AQST) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.